Connect with us

Hi, what are you looking for?

Investing

Acceleration of RAD204 Phase 1 dose escalation trial

Published

Radiopharm Theranostics (RAD:AU) has announced Acceleration of RAD204 Phase 1 dose escalation trial

Download the PDF here.

This post appeared first on investingnews.com

In this article:
Enter Your Information Below To Receive Free Trading Ideas, Latest News And Articles.







    Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

    You May Also Like

    Economy

    Stock Market News UK Update: FTSE 100 & 250 Rise

    Stock Market News: UK Forecast and Technical Analysis Today, the UK stock market saw the FTSE 250 increase by 195 points (0.9%) to 21,628, nearly matching...

    April 8, 2025

    Investing

    Copper Crunch: China’s Stockpiles Depleting, US Demand Rising

    Copper prices are being pushed skyward as China’s stockpiles sit on the verge of depletion and as US demand for the red metal surges,...

    May 7, 2025

    Investing

    Exceptional Lithium Intercept Extends Red Mountain Discovery Further to the North

    Astute Metals NL (ASX: ASE) (“ASE”, “Astute” or “the Company”) is pleased to report assay results from the first of six holes completed as...

    May 19, 2025

    Economy

    BNB Price Surge Leads Crypto Gains as Bitcoin Climbs

    BNB Price Surge Leads Crypto Gains as Bitcoin Climbs The BNB price surge on April 21, 2025, stole the spotlight as Binance Coin jumped...

    April 22, 2025

    Disclaimer: Greenlightinvestings.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


    Copyright © 2024 Greenlightinvestings.com